FDA raised conflict of interest concerns ahead of new peptide panel The Washington Post

FDA raised conflict of interest concerns ahead of new peptide panel  The Washington Post

As the Trump administration was assembling a key panel to review a slate of controversial peptides, FDA officials expressed concerns about appointing those who worked for peptide-related businesses a… [+187 chars]Read More

Leave a Reply

Your email address will not be published. Required fields are marked *